Bachem (BANB.SW) closes CHF55.35 on 10 Mar 2026: earnings due 12 Mar could change outlook

Bachem Holding AG (BANB.SW) closed at CHF55.35 on 10 Mar 2026 as investors positioned ahead of the company’s earnings release scheduled for 12 Mar 2026. BANB.SW stock has pulled back from a 52-week high of CHF76.00 while trading below its 50-day average of CHF64.10, creating a near-term technical and fundamental test for margins and order intake. With EPS at 1.79 and a P/E of 30.34, the market will watch guidance and cash flow detail closely. For primary documents see the company site and our Meyka AI analysis page Bachem website and Meyka BANB.SW page.

Earnings preview: what the market will watch in BANB.SW earnings

BANB.SW earnings on 12 Mar 2026 will centre on margins, order backlog conversion, and free cash flow after operating cash flow weakness. Analysts will compare reported EPS to the company EPS of 1.79 and assess any FY guidance changes. Management commentary on clinical-stage projects and regulatory timelines could move the stock more than near-term sales numbers.

Valuation and fundamentals: BANB.SW stock valuation vs sector

Bachem’s trailing P/E of 30.34 is above the Swiss Basic Materials sector average P/E of 22.46, signalling a premium for growth and specialty drug manufacturing exposure. Key ratios: market cap CHF4071302142.00, price/book 2.99, dividend per share 0.85, current ratio 2.44, and debt/equity 0.04. Strong margins (EBIT margin ~24.12%) support the premium but free cash flow is negative at -1.59 per share, a risk if working capital stays elevated.

Operational readouts and growth signals in the BANB.SW report

Bachem reported revenue growth of 4.84% for FY2024 and net income growth of 7.50%, indicating steady demand for peptide APIs. Watch days-of-inventory at 378.02 and days-sales-outstanding 99.17, which pressure cash conversion. R&D and capex trends matter: capex to revenue is 0.39, and operating cash flow per share stands at 1.93.

Technicals and trading momentum for BANB.SW stock

Technicals show a short-term oversold setup: RSI 29.35 and MACD histogram negative, with Bollinger middle at CHF60.92 and lower band at CHF52.85. Volume today was 129232.00 versus average 128368.00, so the move is on normal liquidity. A break back above the 50-day average CHF64.10 would be a positive momentum trigger.

Meyka AI rates BANB.SW with a score out of 100 and forecast

Meyka AI rates BANB.SW with a score of 70.92 out of 100 (Grade B+, suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a quarterly target of CHF64.13, implying an upside of 15.86% versus the current price CHF55.35. Forecasts are model-based projections and not guarantees.

Analyst context, risks and price targets for BANB.SW stock

Consensus sentiment is neutral with mixed DCF and profitability signals — company rating shows a Neutral recommendation dated 2026-03-09. We outline a three-tier scenario: bull target CHF75.00, base target CHF64.00, bear target CHF46.95 (monthly model). Key risks: inventory days, negative free cash flow per share -1.59, and margin pressure from raw-material costs. Catalysts include stronger-than-expected guidance or margin recovery.

Final Thoughts

Bachem (BANB.SW) enters earnings with the stock at CHF55.35 and clear near-term drivers: margin commentary, cash conversion, and order backlog execution. Fundamentals support a premium P/E of 30.34 given strong operating margins, but negative free cash flow per share -1.59 and high inventory days remain risks. Meyka AI’s forecast model projects a quarterly target of CHF64.13, an implied upside of 15.86% from CHF55.35, while a monthly downside signal sits near CHF46.95. Traders should weigh the technical oversold readings (RSI 29.35) against the company’s operational cash profile and sector comparables in Switzerland’s Basic Materials space on the SIX exchange. Our Meyka AI-powered market analysis flags a balanced risk-reward: potential upside if guidance confirms demand and margins, but measurable downside if cash conversion stalls. Forecasts are model-based projections and not guarantees; always confirm with the company release and primary filings before trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.